BUSINESS
Global Health: In the pink of health, but growth will come at a price
Demand for high-end healthcare facilities remains strong; however, the company’s valuation appears demanding
BUSINESS
Max Healthcare Q1 FY26: Scaling up amid rich valuations
Max plans to increase its capacity by ~70 percent to reach ~9,000 beds by FY28.
BUSINESS
Apollo Hospital: Growth momentum continues in Q1 FY26
Robust expansion plans in place, with a target of about 4,000 beds in the next 3-4 years
BUSINESS
Bluestone Jewellery and Lifestyle IPO: Will it shine on the bourses?
The company is not profitable at the moment and may continue to make losses in the near term
BUSINESS
KIMS: Mixed performance in Q1, but growth story remains resilient
Future growth to be fuelled by several catalysts, and it could emerge as a stronger player in the healthcare space
BUSINESS
Bosch Q1 FY26: Is the auto ancillary stock racing too fast?
Bosch is planning to strengthen its competitive position in the mobility sector and industrial technology. It is actively adding new components, particularly those catering to EVs and advanced electronics.
BUSINESS
Gabriel India: Primed for growth but priced to perfection
Forays into new segments like sunroof, inorganic and organic strategies show the company’s confidence in the future.
BUSINESS
SJS Enterprises Q1 FY26: On track to meet growth targets
SJS expects to grow at 2x the industry volume in FY26 and maintain a ~26 percent margin level.
BUSINESS
Vijaya Diagnostic: Healthy show continues
The management reiterated its guidance of achieving a top-line growth of around 15 percent and maintaining the current margin profile in FY26.
BUSINESS
Brigade Hotel Ventures: Does the IPO offer a good investment opportunity?
The hotelier’s return ratios are solid and the stock valuation is attractive while part of the IPO money will support growth plans
BUSINESS
Should you decorate your portfolio with this auto ancillary stock?
Driven by the growing demand for aesthetics in premium vehicles, SJS expects to grow at 2x the industry volume in FY26.
BUSINESS
Gabriel India: Unlocking new doors of opportunities
The company recently announced a demerger scheme. This move will transform Gabriel from a single product company into a highly diversified mobility solutions provider.
BUSINESS
Is this agrochemical IPO a good bet?
The company plans to invest in a new dry flowable manufacturing plant to add newer formulations in its portfolio.
BUSINESS
Optimism low on this healthcare stock
Medanta has strong capabilities to leverage its brand image. However, near-term growth looks limited
BUSINESS
How is the health of this healthcare stock?
Timely execution and ramp-up of new projects are crucial for faster growth
BUSINESS
This hospital chain is aiming for high growth, but is it already priced in?
Max is on an aggressive expansion path with healthy medium-term growth visibility
BUSINESS
Apollo Hospitals: Annual report card ticks all the right boxes
Robust expansion plans in place with the target to add a total of about 4000 beds in the next 3-4 years
BUSINESS
Fiem Industries Q4 FY25: Sturdy results with a healthy outlook
The company is foraying into the PV segment while exploring opportunities in the EV market
BUSINESS
Rallis India: Stars align in Q2, what does its pitch report say?
The company is focusing on optimising portfolio and streamlining capacities
BUSINESS
Krsnaa Diagnostics: Creating new opportunities for itself
With the ramp-up of new projects and fresh order wins, the current growth trajectory should continue into FY25-26
BUSINESS
What does Advent Group’s equity infusion mean for Apollo Hospital stock?
After the integration of Keimed with AHL, Advent will hold a 12.1% stake in the combined entity.
BUSINESS
Has Sharda Cropchem managed to tide over all the challenges?
Concern around business outlook lingers as international markets may take time to recover
BUSINESS
Max Healthcare: A healthy but pricey stock
The healthcare company’s medium-term revenue growth visibility appears healthy
BUSINESS
Medanta: Charting a growth path
Medanta has strong capabilities to leverage its brand image and win the underserved and growing markets.
